Abbildung 33: EUROPA-Studie - Charakteristika
The analysis of the baseline characteristics of patients recruited into the study showed that: Patients were at least 18 years without clinical evidence of heart failure and with evidence of coronary artery disease. In average they were 60 years old which is not old for coronary artery disease. They were largely men: 86%, weight: 81 + 12, heart rate: 68 + 10 and they had normal blood pressure. Importantly, there were no differences between these two groups, perindpril and placebo, almost identically matched.